These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14602918)

  • 21. Human DNA topoisomerase I: relaxation, roles, and damage control.
    Leppard JB; Champoux JJ
    Chromosoma; 2005 Jul; 114(2):75-85. PubMed ID: 15830206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The mechanism of specific cleavage of supercoiled DNA by human DNA topoisomerase I: the effect of ligand structure on the catalytic step of reaction].
    Bugreev DV; Buneva VN; Nevinskiĭ GA
    Mol Biol (Mosk); 2003; 37(2):325-39. PubMed ID: 12723479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased salt concentration reversibly destabilizes p53 quaternary structure and sequence-specific DNA binding.
    Butcher S; Hainaut P; Milner J
    Biochem J; 1994 Mar; 298 Pt 3(Pt 3):513-6. PubMed ID: 8141761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of a p53 core tetramer bound to DNA.
    Malecka KA; Ho WC; Marmorstein R
    Oncogene; 2009 Jan; 28(3):325-33. PubMed ID: 18978813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How do drug-induced topoisomerase I-DNA lesions signal to the molecular interaction network that regulates cell cycle checkpoints, DNA replication, and DNA repair?
    Kohn KW; Shao RG; Pommier Y
    Cell Biochem Biophys; 2000; 33(2):175-80. PubMed ID: 11325037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of apoptosis in colon cancer cells by a novel topoisomerase I inhibitor TopIn.
    Bae SK; Gwak J; Song IS; Park HS; Oh S
    Biochem Biophys Res Commun; 2011 May; 409(1):75-81. PubMed ID: 21549095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential binding of tumor suppressor p53 to positively or negatively supercoiled DNA involves the C-terminal domain.
    Mazur SJ; Sakaguchi K; Appella E; Wang XW; Harris CC; Bohr VA
    J Mol Biol; 1999 Sep; 292(2):241-9. PubMed ID: 10493872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 DNA binding can be modulated by factors that alter the conformational equilibrium.
    McLure KG; Lee PW
    EMBO J; 1999 Feb; 18(3):763-70. PubMed ID: 9927436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights from the Structure of Mycobacterium tuberculosis Topoisomerase I with a Novel Protein Fold.
    Tan K; Cao N; Cheng B; Joachimiak A; Tse-Dinh YC
    J Mol Biol; 2016 Jan; 428(1):182-193. PubMed ID: 26655023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a minimal functional linker in human topoisomerase I by domain swapping with Cre recombinase.
    Frøhlich RF; Juul S; Nielsen MB; Vinther M; Veigaard C; Hede MS; Andersen FF
    Biochemistry; 2008 Jul; 47(27):7127-36. PubMed ID: 18553933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA.
    Davies DR; Mushtaq A; Interthal H; Champoux JJ; Hol WG
    J Mol Biol; 2006 Apr; 357(4):1202-10. PubMed ID: 16487540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The type IA topoisomerase catalytic cycle: A normal mode analysis and molecular dynamics simulation.
    Xiong B; Burk DL; Shen J; Luo X; Liu H; Shen J; Berghuis AM
    Proteins; 2008 Jun; 71(4):1984-94. PubMed ID: 18186484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SF2/ASF protein binds to the cap region of human topoisomerase I through two RRM domains.
    Kowalska-Loth B; Girstun A; Trzcińska AM; Piekiełko-Witkowska A; Staroń K
    Biochem Biophys Res Commun; 2005 Jun; 331(2):398-403. PubMed ID: 15850773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing T lymphocytes are uniquely sensitive to a lack of topoisomerase III alpha.
    Mönnich M; Hess I; Wiest W; Bachrati C; Hickson ID; Schorpp M; Boehm T
    Eur J Immunol; 2010 Sep; 40(9):2379-84. PubMed ID: 20623552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymes that push DNA around.
    Keck JL; Berger JM
    Nat Struct Biol; 1999 Oct; 6(10):900-2. PubMed ID: 10504717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.
    Lin L; Ozaki T; Takada Y; Kageyama H; Nakamura Y; Hata A; Zhang JH; Simonds WF; Nakagawara A; Koseki H
    Oncogene; 2005 May; 24(21):3385-96. PubMed ID: 15735665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletions at the carboxyl terminus of vaccinia DNA topoisomerase affect DNA binding and enhance distributivity in DNA relaxation.
    Wang LK; Shuman S
    Biochemistry; 1997 Apr; 36(13):3909-16. PubMed ID: 9092821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of gene amplification as a gain-of-function phenotype of mutant p53 proteins.
    El-Hizawi S; Lagowski JP; Kulesz-Martin M; Albor A
    Cancer Res; 2002 Jun; 62(11):3264-70. PubMed ID: 12036943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical Basis of
    Zhou Q; Gomez Hernandez ME; Fernandez-Lima F; Tse-Dinh YC
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of RNA to p53 regulates its oligomerization and DNA-binding activity.
    Yoshida Y; Izumi H; Torigoe T; Ishiguchi H; Yoshida T; Itoh H; Kohno K
    Oncogene; 2004 May; 23(25):4371-9. PubMed ID: 15064727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.